Skip to main content

Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease

Objective

Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensive efforts, no disease-modifying treatments or preventive strategies are available. The lack of specific, sensitive and minimally invasive diagnostics to identify people with early-stage AD to be included in clinical drug intervention trials is among the main reasons for many notable trial failures. The main challenges in developing the required diagnostics are identification of AD biomarkers and development of their detection techniques. The complex and interdisciplinary nature of the research underlines the need for innovative training of a new generation of researchers in the field. BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges. It brings together leading academic and industrial experts from five major consortia in Europe and uses their synergies to build a triple-i research & training platform with the required multidisciplinary expertise and cutting-edge technologies. BBDiag Fellows will be trained under the Vitae Researcher Development Framework innovatively combined with the BBDiag platform for gaining interdisciplinary scientific and transferable skills as well as personal quality, creative thinking and business mind-set. The ETN has a highly innovative research programme for the discovery of AD biomarkers, development of novel biosensing techniques and point of care tools, and for technological exploitation of the diagnostics. These advances will strongly support improved care provision and development of disease-modifying treatments and preventive strategies for AD patients. More importantly, BBDiag will deliver its first generation of 13 highly-skilled, creative and entrepreneurial Fellows, setting them on a path to successful careers in academia or industry to ensure that the medical and societal challenges imposed by AD are met.

Call for proposal

H2020-MSCA-ITN-2016
See other projects for this call

Coordinator

UNIVERSITY OF PLYMOUTH
Address
Drake Circus
PL4 8AA Plymouth
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 849 242,09

Participants (9)

DANMARKS TEKNISKE UNIVERSITET
Denmark
EU contribution
€ 290 081,88
Address
Anker Engelundsvej 1 Bygning 101 A
2800 Kgs Lyngby
Activity type
Higher or Secondary Education Establishments
NORDIC BIOSCIENCE A/S
Denmark
EU contribution
€ 290 081,88
Address
Herlev Hovedgade 205-207
2730 Herlev
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Italy
EU contribution
€ 424 582,56
Address
Via Mario Negri 2
20156 Milano
Activity type
Research Organisations
PROGNOMICS LTD
United Kingdom
EU contribution
€ 212 557,24
Address
Broomfield & Alexander Ltd Charter Court Phoenix Way Enterprise Park
SA7 9FS Swansea
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SWANSEA UNIVERSITY
United Kingdom
EU contribution
€ 273 287,88
Address
Singleton Park
SA2 8PP Swansea
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Italy
EU contribution
€ 516 122,64
Address
Piazzale Aldo Moro 5
00185 Roma
Activity type
Higher or Secondary Education Establishments
CENTRO DE INVESTIGACION BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS
Spain
EU contribution
€ 247 872,96
Address
"Hospital Universitario ""Virgen Del Rocio"" - Edif. De Laboratorios, 2A Planta - Avda. Manual Siurot S/n"
41013 Sevilla
Activity type
Research Organisations
UNIVERSITATSMEDIZIN ROSTOCK
Germany
EU contribution
€ 249 216,48
Address
Schillingallee 35
18055 Rostock
Activity type
Higher or Secondary Education Establishments
ADVANCED MEDICAL PROJECTS SOCIEDAD LIMITADA

Participation ended

Spain
EU contribution
€ 81 935,78
Address
Avda Chiloeches Num 73
19160 Guadalajara
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partners (4)

HUNAN UNIVERSITY
China
Address
Lushan South Road 1
410082 Changsha
Activity type
Higher or Secondary Education Establishments
China Capital Medical University
China
Address
Xi Tou Tiao, You An Men Wai 10
100069 Beijing
Activity type
Higher or Secondary Education Establishments
ENGAGE - KEY TECHNOLOGY VENTURES AG
Germany
Address
Bahnhofstrasse 54
76137 Karlsruhe
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Re:Cognition Health Ltd.
United Kingdom
Address
45 Queen Anne Street
W1G 9JF London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)